title: Is pathological gambling in Parkinson's disease reduced by amantadine?
authors.forename: Jee-Young
authors.initials: JY
authors.lastname: Lee
authors.forename: Han-Joon
authors.initials: HJ
authors.lastname: Kim
authors.forename: Beom S
authors.initials: BS
authors.lastname: Jeon
mesh_terms: D000368:Aged; D000547:Amantadine / Q000627:therapeutic use*; D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007174:Disruptive, Impulse Control, and Conduct Disorders / Q000188:drug therapy / Q000517:prevention & control / Q000523:psychology; D005260:Female; D005715:Gambling / Q000139:chemically induced* / Q000188:drug therapy* / Q000523:psychology; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy* / Q000523:psychology; D016032:Randomized Controlled Trials as Topic / Q000592:standards / Q000706:statistics & numerical data; D016896:Treatment Outcome
chemical_list: D000978:Antiparkinson Agents; D007980:Levodopa; D000547:Amantadine